The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
The Aenova Group, one of Europe’s leading manufacturers of solid oral-dosage forms, says it is relocating its manufacturing operations for effervescent products from Bioggio, Switzerland, to Bad Aibling, Germany. The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
To accommodate the effervescent manufacturing in May next year, the Bad Aibling site is installing two GMP-compliant production lines.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.